Letter Re: A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness.
Zhang Pei, Han Yihui, Cai Zhaolun, +1 more·European journal of cancer (Oxford, England : 1990)
Abstract not available